Private Management Group Inc. Cuts Stock Holdings in Bausch Health Companies Inc. (NYSE:BHC)

Private Management Group Inc. trimmed its holdings in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 15.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,265,250 shares of the company's stock after selling 227,813 shares during the quarter. Private Management Group Inc. owned 0.35% of Bausch Health Companies worth $10,198,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. DGS Capital Management LLC purchased a new stake in Bausch Health Companies during the fourth quarter valued at approximately $143,000. SG Americas Securities LLC increased its position in shares of Bausch Health Companies by 62.0% during the 4th quarter. SG Americas Securities LLC now owns 3,301,981 shares of the company's stock valued at $26,614,000 after purchasing an additional 1,263,706 shares during the last quarter. Merit Financial Group LLC purchased a new stake in Bausch Health Companies during the 4th quarter valued at $228,000. Sanders Morris Harris LLC lifted its position in Bausch Health Companies by 16.0% in the fourth quarter. Sanders Morris Harris LLC now owns 28,975 shares of the company's stock worth $234,000 after buying an additional 4,000 shares during the last quarter. Finally, Range Financial Group LLC purchased a new position in Bausch Health Companies during the fourth quarter worth $1,004,000. Institutional investors own 78.65% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on BHC shares. Jefferies Financial Group reissued a "hold" rating and issued a $8.00 target price (down previously from $12.00) on shares of Bausch Health Companies in a research note on Thursday. Evercore ISI raised shares of Bausch Health Companies to a "hold" rating in a research report on Tuesday, October 15th. StockNews.com upgraded Bausch Health Companies from a "hold" rating to a "buy" rating in a research report on Friday, October 25th. Finally, Royal Bank of Canada reduced their price target on Bausch Health Companies from $11.00 to $10.00 and set a "sector perform" rating on the stock in a report on Thursday, January 30th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, Bausch Health Companies presently has an average rating of "Hold" and an average target price of $7.42.

Bausch Health Companies Price Performance

BHC stock traded down $0.10 during mid-day trading on Friday, reaching $6.45. The company had a trading volume of 1,790,791 shares, compared to its average volume of 3,757,992. The firm has a 50 day moving average of $7.65 and a 200 day moving average of $7.44. Bausch Health Companies Inc. has a 12 month low of $3.96 and a 12 month high of $11.46.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.